ON Partners' 2025 Women's Report Reveals the Pay Gap Between Executive Men and Women Continues to Narrow
CLEVELAND, March 26, 2025 (GLOBE NEWSWIRE) -- ON Partners, a pure-play retained executive search firm building diverse C-level and board leadership teams, has released its 2025 Women's Report in honor of Women's History Month. The report, which analyzes over 1,000 senior-level executive searches over the last few years within ON Partners' proprietary database, shows the gap between executive men and executive women's compensation is narrowing and women are gaining ground in senior leadership (SVP) roles.
The World Economic Forum's June 2024 Global Gender Gap research study found that in North America, it will take 106 years for women to achieve economic parity with men. ON Partners' research shows a better outlook in the executive suite.
The Report revealed that the average total compensation for executive women was $457k compared to executive men's average of $486k. The $29k difference comes in lower than last year's difference of $36k. In addition, compensation for both men and women increased in 2024, with women's compensation increasing at a higher rate than men's.
A notable finding is that while the compensation gap continues to narrow, women come in lower than men on total compensation often due to lower bonuses and sign-on bonuses.
'It is important for women to evaluate their total compensation package, not just their guaranteed base salaries,' said Tara Flickinger, partner at ON Partners. 'Companies are unlikely to offer a sign-on bonus unless there is an ask from the candidate in the negotiation process and the same is true on bonus potential. The latter is crucial because asking for an increase in performance-based compensation signals a candidate is betting on herself, which is music to hiring managers' ears.'
The top senior-level placements of CEO and COO still have a wide disparity with women appointments coming in at 8.1% and 9.1%, respectively. However, a positive trend is that senior leadership roles (SVP level), which are often a pipeline to the C-Suite, show women getting about 25% of the placements with total compensation being slightly higher than their male counterparts.
'The trendline of more women in pipeline roles is not at all surprising,' said Bryan Buck, managing partner at ON Partners. 'The investment in talent development over the last decade is continuing to show exponential returns – not just with more women in positions of leadership today, but in the path they're creating for the next generation that's having a compounding effect. Women today aren't just leading by example, they're bringing it to life for those who are up next.'
Other findings include:
The CFO role is one in which women are making strides in compensation. Women are just above 20% of CFO placements, and their total compensation is higher with an average of $450k vs. $440k.
Women are making strides in tech roles, which have traditionally favored male executives. Among the CTO and CITO positions ON Partners has placed over the past two years, the top earners have been female executives. Chief Product Officer (CPO) compensation is also very comparable between men and women.
'The CIO and CTO functions have historically been highly technical, requiring deep engineering expertise, but these roles have evolved,' said Nina McMaster, partner at ON Partners. 'Today, these leaders are viewed not just through a technical lens, but as business-critical positions requiring leadership, strategy, communication, and the ability to collaborate across departments. Companies are recognizing that a diverse leadership team brings better decision-making and business outcomes. The result is more negotiating power for women when moving into these positions.'
About ON Partners
Established in 2006, ON Partners is the only pure-play executive search firm building diverse C-level and board leadership teams. We rebuilt the institution of executive search for the way you work, with an approach that includes present partners who engage with clients from the first brief to the final decision, individually crafted solutions unique to each client, and an easier experience overall. Named by Forbes as one of America's Best Executive Recruiting Firms and to the Inc. 500/5000 List nine times, ON Partners is consistently ranked among the top 20 retained executive search firms in the U.S.
Media Contact
Jennifer Greene
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
15 minutes ago
- Yahoo
Gene Therapy Collaboration and Licensing Deals Report and Directory 2025: Explore the Financials Behind 787 Gene Therapy Licensing Deals from 2016-2025
The Gene Therapy Collaboration and Licencing Deals report features 787 deals with financial terms and SEC contracts. Explore trends in R&D partnerships, commercialization strategies, and IP structures. Ideal for benchmarking deal terms, assessing opportunities, and streamlining due diligence in the gene therapy space. Dublin, June 12, 2025 (GLOBE NEWSWIRE) -- The "Gene Therapy Collaboration and Licensing Deals 2016-2025" report has been added to report contains a comprehensive listing of 787 gene therapy deals announced since 2016, including financial terms where available, and links to online deal records of actual gene therapy partnering deals as disclosed by the deal parties. In addition, where available, records include contract documents as submitted to the Securities Exchange Commission by companies and their partners. Gene Therapy Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented access to the gene therapy deals entered into by the world's leading biopharma revised and updated, the report provides details of gene therapy deals from 2016 to report provides a detailed understanding and analysis of how and why companies enter gene therapy deals. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of report includes collaboration, development, research and licensing initial chapters of this report provide an orientation of gene therapy dealmaking. Chapter 1 introduces the report, while Chapter 2 provides an overview of the trends in gene therapy dealmaking since 2016. Chapter 3 offers a summary of the leading gene therapy deals since 2016, listed by headline value. Chapter 4 lists the top 25 most active companies in gene therapy dealmaking, with summaries and comprehensive listings of deals. Chapter 5 and Chapter 6 offer detailed reviews of gene therapy deals and partnering deals announced since Jan 2016, focusing on contract documents in the public domain and specific gene therapy technologies report also includes numerous tables and figures that illustrate the trends and activities in gene therapy deal making since 2016. In addition, a comprehensive deal directory is provided, organized by company A-Z, deal type, and therapeutic target. Each deal title links via Weblink to an online version of the deal record and, where available, the contract document, providing easy access to each contract document on Therapy Collaboration and Licensing Deals provides the reader with the following key benefits: Understand deal trends since 2016 Browse gene therapy collaboration and licensing deals Benchmark analysis - identify market value of transactions Financials terms - upfront, milestone, royalties Directory of deals by company A-Z, deal type and therapy area Leading deals by value Most active dealmakers Identify assets and deal terms for each transaction Access contract documents - insights into deal structures Due diligence - assess suitability of your proposed deal terms for partner companies Save hundreds of hours of research time Report ScopeGene Therapy Collaboration and Licensing Deals is intended to provide the reader with an in-depth understanding of gene therapy trends and structure of deals entered into by leading biopharma companies Therapy Collaboration and Licensing Deals includes: Trends in gene therapy dealmaking in the biopharma industry Directory of gene therapy deal records covering pharmaceutical and biotechnology The leading gene therapy deals by value Most active gene therapy licensing dealmakers Gene Therapy Collaboration and Licensing Deals provides comprehensive access to available records for deals, including contract documents where contract agreements allows due diligence of: What are the precise rights granted or optioned? What is actually granted by the agreement to the partner company? What exclusivity is granted? What is the payment structure for the deal? How are sales and payments audited? What is the deal term? How are the key terms of the agreement defined? How are IPRs handled and owned? Who is responsible for commercialization? Who is responsible for development, supply, and manufacture? How is confidentiality and publication managed? How are disputes to be resolved? Under what conditions can the deal be terminated? What happens when there is a change of ownership? What sublicensing and subcontracting provisions have been agreed? Which boilerplate clauses does the company insist upon? Which boilerplate clauses appear to differ from partner to partner or deal type to deal type? Which jurisdiction does the company insist upon for agreement law? Key Topics Covered:Chapter 1 - IntroductionChapter 2 - Trends in gene therapy dealmaking2.1. Introduction2.2. Gene therapy deals over the years2.3. Most active gene therapy dealmakers2.4. Gene therapy deals by deal type2.5. Gene therapy deals by therapy area2.6. Gene therapy deals by industry sector2.7. Deal terms for gene therapy deals2.7.1 Gene therapy deals headline values2.7.2 Gene therapy deal upfront payments2.7.3 Gene therapy deal milestone payments2.7.4 Gene therapy royalty ratesChapter 3 - Leading gene therapy deals3.1. Introduction3.2. Top gene therapy deals by valueChapter 4 - Most active gene therapy dealmakers4.1. Introduction4.2. Most active gene therapy dealmakers4.3. Most active gene therapy deals company profilesChapter 5 - Gene therapy contracts dealmaking directory5.1. Introduction5.2. Gene therapy contracts dealmaking directoryChapter 6 - Gene therapy dealmaking by technology typeDeal directory Deal directory - Gene therapy deals by company A-Z Deal directory - Gene therapy deals by deal type Deal directory - Gene therapy deals by therapy area For more information about this report visit About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. CONTACT: CONTACT: Laura Wood,Senior Press Manager press@ For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900
Yahoo
15 minutes ago
- Yahoo
Monaco: at the Yacht Club, Blumorpho pushes maritime finance forward, 'No time to waste'
MONACO, June 12, 2025 (GLOBE NEWSWIRE) -- The ecological transition of the maritime and port sectors has reached a critical inflection point. In a high-level working session held at the Yacht Club de Monaco, innovation met finance to chart a clear course toward healthier oceans and sustainable infrastructure. The event, led by Blumorpho in partnership with the International Association of Port Cities (AIVP) and supported by the Prince Albert II of Monaco Foundation, brought together port authorities, financial institutions, corporations, and innovators to activate actionable financial mechanisms for the sustainable transformation of coastal urban ecosystems. Part of the momentum building toward the 'Blue Economy Finance Forum' and the UN Ocean Conference (UNOC), the initiative aims to accelerate the deployment of scalable, investable solutions in support of net-zero and biodiversity objectives. Opening the session, Bernard d'Alessandri, General Secretary of the Yacht Club de Monaco, stated: 'On behalf of our President, HSH Prince Albert II, we are pleased to welcome you to the Yacht Club de Monaco to address this key issue. We would like to congratulate the Blumorpho team for their initiative and leadership. On our side, and as part of our collective ambition, 'Monaco, Capital of Advanced Yachting', we are fully committed to advancing sustainable yachting through concrete actions, including the development of the SEA Index®, a tool to assess the carbon footprint of superyachts; and support for pioneering projects through the Monaco Energy Boat Challenge (1–5 July 2025). This commitment is more essential than ever, and we are proud to contribute to the dialogue on how to protect our Ocean.' The day unfolded through expert panels, collaborative workshops, and project showcases, with three core themes emerging: ports as platforms for systemic innovation, strategic capital for climate impact, and concrete, investment-ready projects. Port cities were highlighted as drivers of integrated innovation, connecting clean energy, biodiversity, mobility, and industrial transformation. Financially, new models are gaining traction, from blended finance and blue bonds to private equity and infrastructure debt. Flagship projects from Kribi, Riga, San Diego, Genoa, and Bordeaux showcased pathways that combine decarbonization, aquaculture, digital infrastructure, and inclusive growth. 'The real challenge is not only funding the transition, but designing collaborative and business models that align profitability with long-term climate and societal goals,' explained Géraldine Andrieux, CEO of Blumorpho. Featured case studies included Ineos Energy's integrated approach to carbon capture and storage, and Republic Bank's expanding role in green infrastructure across Caribbean ports and beyond. 'As key players in the globalisation of trade, port cities bear a large share of the responsibility for the climate change. But the richness of their ecosystem means that they are also home to some of the solutions,' said Bruno Delsalle, General Manager of AIVP. The session sets the stage for a shared roadmap to be presented at the AIVP World Conference Cities & Ports 2025, scheduled in New York this November. Tisha Marajh, Group Sustainability Officer at Republic Bank, concluded with a firm call to action: 'We don't have time to waste. We are among the most affected by climate change. Phased investments tailored to attract different kinds of financing can provide a more sustainable path forward. We also need systems to identify small upstream projects, manage ESG risks, and facilitate technology transfer. Sustainable finance is a market opportunity, and we, as financial institutions, are ready to engage, if the right conditions are in place, in Caribbeans and at global scale.' For more information:- A photo accompanying this announcement is available at in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
18 minutes ago
- Yahoo
Japan Baby Care Products Market Competition, Forecast & Opportunities Report 2025: Major Players in Japan's Baby Care Market Focus on Quality and Innovation
The Japan Baby Care Products Market is expanding, driven by higher per-child spending and a demand for sustainable, health-conscious products. Opportunities include leveraging e-commerce, catering to organic and culturally preferred ingredients, and aligning with government policies on nutrition and sustainability. Japanese Baby Care Products Market Dublin, June 12, 2025 (GLOBE NEWSWIRE) -- The "Japan Baby Care Products Market, By Region, Competition, Forecast & Opportunities, 2020-2030F" has been added to offering. The Japan Baby Care Products Market was valued at USD 8.56 Billion in 2024 and is expected to reach USD 12.06 Billion by 2030, rising at a CAGR of 5.88%. Despite a declining birth rate, the market continues to expand, driven by higher per-child spending and a shift toward sustainable and health-conscious baby products. Japanese consumers increasingly favor organic and natural items in segments such as lotions, shampoos, wipes, and diapers, reflecting heightened concerns around product safety and skin sensitivity. The demand for high-quality, safe baby care items is further supported by the country's strong appreciation for artisanal and culturally inspired ingredients. Meanwhile, the rapid expansion of e-commerce and omnichannel retail is increasing accessibility to a wider variety of baby products. In line with this, Japan's eCommerce sector is forecast to generate revenue of USD 190.53 billion by 2025. These trends underscore the market's resilience and evolving consumer preferences, shaping its trajectory through the next decade. Key Market Drivers: Government Initiative & Policies Supporting the Food Sector The Japanese government has rolled out strategic initiatives aimed at improving nutrition among families, particularly focusing on pregnant women and young children. A core part of this effort is the Measures for Achievement of Decarbonization and Resilience with Innovation (MeaDRI), targeting zero CO2 emissions in agriculture and food systems by 2050 through sustainable practices and waste reduction. These policies support healthier food systems and reinforce the broader baby care ecosystem. The Tokyo Nutrition for Growth Summit 2021 Action Plan is another key initiative, emphasizing collaborative medical and governmental education campaigns to enhance maternal nutrition and reduce underweight pregnancies. These policies, combined with measures against childhood obesity and a stable regulatory environment, are strengthening the outlook for the baby food and baby care product markets. Key Market Challenges: Declining Birth Rate A significant obstacle for Japan's baby care products market is the continued drop in birth rates. As of 2024, Japan recorded approximately 720,000 births-the lowest since records began-reflecting a 5% decline from the previous year. This demographic shift is shrinking the consumer base for baby products, prompting major companies to reconsider domestic operations. For example, Oji Holdings ceased domestic baby diaper production to pivot toward adult incontinence products, reflecting changing market priorities. Japan's aging population, with nearly 30% aged 65 or above, exacerbates the challenge by reducing the workforce and economic productivity. While government incentives for childbirth and childcare support exist, their impact has yet to reverse the downward trend, posing long-term implications for the baby care industry. Key Market Trends: Cultural Preferences for Traditional Ingredients Cultural affinity for traditional, natural ingredients strongly influences consumer preferences in Japan's baby care segment. Parents are increasingly drawn to products incorporating heritage-based, gentle ingredients such as rice bran oil for its moisturizing properties, green tea extract for its soothing benefits, and sakura (cherry blossom) extract for its symbolic and aesthetic appeal. These components not only meet the demand for skin-friendly and safe formulations but also reflect deep-rooted cultural values. As such, manufacturers are embedding these traditional elements into baby care lines to resonate with consumers seeking authenticity and quality. This trend enhances product differentiation and reinforces local identity in a competitive and globalized market. Key Market Players: Oji Holdings Corporation Morinaga Milk Industry Co., Ltd Meiji Holdings CO., Ltd Asahi Group Foods, Ltd Miki Shoko Co., Ltd The Procter & Gamble Company Kimberly-Clark Corporation Kenvue Brands Unicharm Corporation Himalaya Wellness Company Report Scope: In this report, the Japan Baby Care Products Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below: Japan Baby Care Products Market, By Product Type: Skin Care Toiletries Hair Care Food & Beverages Others Japan Baby Care Products Market, By Age Group: 0-12 Months 13-24 Months 24-48 Months Japan Baby Care Products Market, By Sales Channel: Supermarkets/Hypermarkets Specialty Stores Pharmacies/Drug Stores Online Others Japan Baby Care Products Market, By Region: Hokkaido & Tohoku Chubu Chugoku Kyushu Rest of Japan Key Attributes: Report Attribute Details No. of Pages 82 Forecast Period 2024 - 2030 Estimated Market Value (USD) in 2024 $8.56 Billion Forecasted Market Value (USD) by 2030 $12.06 Billion Compound Annual Growth Rate 5.8% Regions Covered Japan For more information about this report visit About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. Attachment Japanese Baby Care Products Market CONTACT: CONTACT: Laura Wood,Senior Press Manager press@ For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900Sign in to access your portfolio
